We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Hematopoietic Stem Cell Transplantation in Refractory Crohn's Disease: Should It Be Considered?
- Authors
Reider, Simon; Binder, Lukas; Fürst, Stefan; Hatzl, Stefan; Blesl, Andreas
- Abstract
Hematopoietic stem cell transplantation (HSCT) is widely used in benign and malignant hematological diseases. During the last decade, HSCT, mainly autologous, also gained increasing attention in the treatment of refractory autoimmune diseases. Crohn's disease (CD) is an inflammatory bowel disease leading to transmural inflammation potentially affecting all parts of the luminal gastrointestinal tract. Despite improving therapeutic options, including various biologics, some patients are refractory to all lines of available conservative therapy, leading to increased morbidity and reduced quality of life. Apart from surgery, HSCT might be a reasonable treatment alternative for refractory CD patients. This review aims to describe the current role of HSCT in CD and discusses the procedure, the correct patient selection, the clinical efficacy from initial remission to following relapse rates, and complications of this treatment.
- Subjects
HEMATOPOIETIC stem cell transplantation; CROHN'S disease; INFLAMMATORY bowel diseases; DEEP brain stimulation; BLOOD diseases; BRAIN stimulation; CONSERVATIVE treatment
- Publication
Cells (2073-4409), 2022, Vol 11, Issue 21, p3463
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells11213463